Updated December 7, 2023
A number of states have enacted drug pricing transparency laws requiring drug supply chain entities such as manufacturers, pharmacy benefit managers, health plans, and others to report information explaining high price increases and high-priced new drugs. This chart compares states’ transparency laws, each tab provides an overview of required reporting from specific supply chain entities. To learn more about how states are implementing transparency laws and reporting on high drug prices, explore the Center for State Rx Drug Pricing’s Administrative Action tracker.
